Fragment 176-191, also known as HGH Frag 176-191, is a modified peptide fragment of human growth hormone (hGH). Specifically, it consists of the amino acids 176-191 from the C-terminal end of the hGH molecule. This fragment is designed to stimulate fat breakdown without promoting muscle growth, distinguishing it from the full hGH protein. HGH Frag 176-191 has shown potential as a lipolytic (fat-reducing) agent and has been explored for its ability to help with weight loss and fat reduction.
Additionally, studies are exploring its potential applications beyond weight management, including as a treatment for certain cancers when used in nanoparticle form to enhance its effectiveness against cancer cells, particularly in breast cancer research[1].
en.wikipedia.org – HGH Fragment 176–191
pmc.ncbi.nlm.nih.gov – Human Growth Hormone Fragment 176–191 Peptide
tandfonline.com – Human Growth Hormone Fragment 176–191 Peptide
pubmed.ncbi.nlm.nih.gov – Human Growth Hormone Fragment 176-191 Peptide
journals.physiology.org – Effects of oral administration of a synthetic fragment of human
semanticscholar.org – Human Growth Hormone Fragment 176–191 Peptide